body composition raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2026-04-01. Anything still debated is marked as such rather than presented as settled.
瑞他鲁肽是一种在研合成肽，同时作用于胰高血糖素样肽-1、葡萄糖依赖性促胰岛素多肽和胰高血糖素受体。该分子属于多受体激动剂类别，尚未获得任何监管机构的上市批准。当前临床开发主要针对肥胖和2型糖尿病，研究代号为LY3437943。已确立的信息包括受体靶点和部分中期试验结果；最终疗效、长期安全性和适用人群仍属开放问题。
开发进程从早期单次和多次给药研究推进至大规模后期试验。公开报告显示，参与者在体重和相关代谢指标上出现变化，但完整数据需经同行评审并接受独立复核。试验设计通常包括随机、双盲和对照设置，以区分药物效应与行为干预。监管提交和标签范围尚未确定；长期维持效果与心血管结局仍是开放问题。
Trial reports for this compound rely on a small set of repeated measures. Body weight is normally expressed as percent change from baseline at a fixed week, with absolute kilograms given secondarily. Glycemic endpoints include HbA1c, fasting glucose, and, in some protocols, continuous glucose monitoring summaries. Imaging endpoints such as MRI-derived proton density fat fraction quantify liver fat. Standardization matters because a percent change and a categorical responder analysis can tell different stories about the same dataset.
Body composition is assessed with dual-energy X-ray absorptiometry or comparable methods, which separate fat mass from lean mass. Reported losses include both compartments, and the ratio between them is a subject of ongoing analysis rather than a settled result. Waist circumference, blood pressure, and lipid panels are collected as supporting measures. Resting energy expenditure and substrate oxidation are measured in smaller mechanistic studies, where glucagon receptor activity is expected to matter. These substudies are typically short and small, so their findings carry wide uncertainty.
| Property | Value | Notes |
|---|---|---|
| 研究代号 | LY3437943 | 文献中常用的实验标识 |
| 药物类别 | 三重受体激动剂 | 靶向GLP-1、GIP与胰高血糖素受体 |
| 开发状态 | 后期临床研究 | 尚未获批上市 |
| 主要研究人群 | 肥胖与2型糖尿病 | 入组条件依试验方案而定 |
| 常见同义词 | 瑞他鲁肽；LY3437943 | 名称拼写可能因语言和出版物而异 |
Retatrutide is an investigational synthetic peptide that acts on three receptor targets at once: glucose-dependent insulinotropic polypeptide, glucagon-like peptide-1, and glucagon. It is developed by Eli Lilly and appears in the literature and in trial registries under the code LY3437943. The molecule belongs to a class of engineered peptides designed to resist rapid breakdown and permit infrequent subcutaneous administration. No regulatory agency has approved it for clinical use, and all available human data come from controlled trials rather than from routine practice.
The intended pharmacology combines three signals in one molecule. GLP-1 receptor activation reduces appetite and slows gastric emptying, effects already exploited by approved incretin-based therapies. GIP receptor engagement is associated with improved insulin sensitivity and with direct effects on adipose tissue, although how much it contributes to overall outcomes is still debated. Glucagon receptor agonism raises energy expenditure and supports hepatic lipid handling, a mechanism that also tends to increase glucose output. The triple profile is hypothesized to produce a larger metabolic effect than single or dual agonism, but the relative weight of each receptor in humans is not settled.
该化合物处于临床试验阶段，尚未在多数地区取得上市许可。公开信息主要来自企业公告、学术会议摘要与试验注册平台记录，完整数据仍在逐步披露。关于长期疗效与安全性的判断，需要等待规模更大、随访更久的研究结果，目前不宜对最终结论作出预判。
retatrutide 是一种人工合成的多肽，设计目标是同时作用于 GIP、GLP-1 与胰高血糖素三种受体。这种三重激动设计试图把多条代谢通路的调节整合进单一分子，而不是只依赖一种肠促胰素受体。分子骨架以天然肽序列为基础，经过非天然氨基酸替换和脂肪酸侧链修饰，以获得更长的作用时间。该方向属于多受体激动剂研究的一部分，与双重激动剂的工作并行推进。
Netherlands: Prime Minister Dick Schoof stated that the Dutch cabinet was "closely following the developments in the Caribbean region and the situation in Venezuela following the US attacks," saying that "safety in the region is of great importance to Aruba, Curaçao and Bonaire." Foreign Affairs Minister David van Weel stated that "The Kingdom of the Netherlands does not recognise the Maduro regime and calls for a swift return to democracy. The Netherlands urges all parties to prevent further escalation and to adhere to international law." Norway: Minister of Foreign Affairs Espen Barth Eide stated that even though Norway does not recognize the legitimacy of Maduro's presidency, the American military operation marked "a grave escalation of an already highly volatile situation" and that it was "not in accordance with international law." Poland: Prime Minister Donald Tusk stated that the "U.S. strike on Venezuela affects the entire world," and that he hoped that 2026 would not be more eventful than 2025. Portugal: Prime Minister Luís Montenegro stated that the Portuguese government is "focused on the future and on the restoration of a full democracy in which Venezuelans can freely choose their future." and that the government is "taking note of President Trump and the role of the United States in promoting a stable, peaceful, democratic, and inclusive transition in Venezuela as swiftly as possible.
Examples of vertebrate and invertebrate necrophages (species names and dietary information with supporting references) from Zenodo datasets Maggot medicine (a video on maggot therapy) from National Geographic The museum in lockdown: who feeds the beetles (a video on dermestid beetles) from the Natural History Museum Eternal horizons (a podcast on sky burial) from BBC Audio
In food processing, fermentation is the conversion of carbohydrates to alcohol or organic acids using microorganisms—yeasts or bacteria—without an oxidizing agent being used in the reaction. Fermentation usually implies that the action of microorganisms is desired. The science of fermentation is known as zymology or zymurgy. The term "fermentation" sometimes refers specifically to the chemical conversion of sugars into ethanol, producing alcoholic drinks such as wine, beer, and cider. However, similar processes take place in the leavening of bread (CO2 produced by yeast activity), and in the preservation of sour foods with the production of lactic acid, such as in sauerkraut and yogurt. Other widely consumed fermented foods include vinegar, olives, and cheese. More localized foods prepared by fermentation may also be based on beans, grain, vegetables, fruit, honey, dairy products, and fish.
Sources: en.wikipedia.org
=== Autoimmune diseases === Monoclonal antibodies used for autoimmune diseases include infliximab and adalimumab, which are effective in rheumatoid arthritis, Crohn's disease and ulcerative colitis by their ability to bind to and inhibit TNF-α. Basiliximab and daclizumab inhibit IL-2 on activated T cells and thereby help preventing acute rejection of kidney transplants. Omalizumab inhibits human immunoglobulin E (IgE) and is useful in moderate-to-severe allergic asthma.
Research on the viability of this new technique, as well as many others, as a means of monitoring the levels of rBST in dairy cattle continues to be an issue of practicality, profitability, and humaneness towards livestock in the dairy industry.
The Meiji government assured the foreign powers that it would follow the old treaties negotiated by the bakufu and announced that it would act in accordance with international law. Mutsuhito, who was to reign until 1912, selected a new reign name—Meiji, or "Enlightened Rule"—to mark the beginning of a new era in Japanese history. To further dramatize the new order, the capital was relocated from Kyoto, where it had been situated since 794, to Tokyo (Eastern Capital), the new name for Edo. In a move critical for the consolidation of the new regime, most daimyōs (feudal lords) voluntarily surrendered their land and census records to the Emperor in the abolition of the Han system, symbolizing that the land and people were under the Emperor's jurisdiction. Confirmed in their hereditary positions, the daimyo became governors, and the central government assumed their administrative expenses and paid samurai stipends. The han were replaced with prefectures in 1871, and authority continued to flow to the national government. Officials from the favored former han, such as Satsuma, Chōshū, Tosa, and Hizen staffed the new ministries. Formerly old court nobles, and lower-ranking samurai, replaced bakufu appointees and daimyo as a new ruling class appeared.
Sources: en.wikipedia.org
Mahathir was born at his parents' home in a poor neighbourhood at Lorong Kilang Ais, Alor Setar, in the capital of the Malay sultanate of Kedah under a British protectorate, on 10 July 1925. He was the first prime minister who was not born into the aristocracy or a prominent religious or political family. Mahathir's mother, Wan Tempawan Wan Hanapi, was a Malay from Kedah. His father, Mohamad Iskandar, was from Penang of Malay and Indian descent. Mahathir's paternal grandfather had come from Kerala, British India. Some claim that Mahathir's facial features resemble those of Kerala Chief Minister Pinarayi Vijayan, although they are not related. Mohamad Iskandar was the principal of an English-medium secondary school, whose lower-middle-class status meant his daughters were unable to enrol in a secondary school. Wan Tempawan Wan Hanapi had only distant relations to members of Kedah's royalty. Both had been married previously. Mahathir was born with six half-siblings and two full-siblings. His childhood home, with a single shared bedroom and no electricity supply, was later converted to a tourist attraction and opened to the public. During his childhood, Mahathir enjoyed playing snakes and ladders and demonstrated multiple creative talents, including playing the trumpet, interior decorating, and engaging in crafts and carpentry work. He once shared that he was bullied in his youth, recalling how he sold balloons for a small profit but was forced by a stronger peer to use his earnings to buy food for him.
When cannabis is cultivated for its psychoactive or medicinal properties, male plants will often be separated from females. This prevents fertilization of the female plants, either to facilitate sin semilla flowering or to provide more control over which male is chosen. Pollen produced by the male is caught and stored until it is needed. When a male plant of one strain pollinates a female of another strain, the seeds will be F1 hybrids of the male and female. These offspring will not be identical to their parents. Instead, they will have characteristics of both parents. Repeated breeding results in certain characteristics appearing with greater regularity. It is impossible for a hermaphrodite to create any male-only seeds. A hermaphrodite may create female only seeds and hermaphrodite seeds. Also the female-only seeds may carry the hermaphrodite trait. Hybridization is the process of plants and animals breeding. Natural wind currents help speed up this hybridization process and promotes a positive growth. Some plants produce many seeds while some produce little to none depending on how it is bred. If seeds are produced traits from both the original parents will be expressed. Techniques such as mutation breeding are used to develop new strains using irradiation or chemical mutagens such as colchicine. Various companies have been experimenting with creating new strains using genetic engineering techniques.
This contradicts information published earlier in a Wired article, which states that the hyperthymesiac Jill Price had been brain scanned and her "hippocampus and prefrontal cortex were reportedly normal", suggesting that these regions of the brain do not need to be different for hyperthymesia to occur. Significant debate also exists over the limits of memory capacity. Some are of the view that the brain contains so many potential synaptic connections that, in theory at least, no practical limit exists to the number of long-term memories that the brain can store. In 1961, Wilder Penfield reported that specific stimulation of the temporal lobes resulted in vivid recollection of memories. He concluded that our brains were making "continuous, effortless, video-like recordings" of our experiences, but that these records are not consciously accessible to us. However, a study published in the Proceedings of the National Academy of Sciences suggested that hyperthymesiacs may reconstruct memories from traces and incorporate post-event information and associations—a finding at odds with Penfield's video-like recording analogy.
1993/2614) Northampton Community Healthcare National Health Service Trust (Establishment) Order 1993 (S.I. 1993/2615) Bishop Auckland Hospitals National Health Service Trust (Establishment) Order 1993 (S.I. 1993/2616) Carlisle Hospitals National Health Service Trust (Establishment) Order 1993 (S.I. 1993/2617) Cheviot and Wansbeck National Health Service Trust (Establishment) Order 1993 (S.I. 1993/2618) City Hospitals Sunderland National Health Service Trust (Establishment) Order 1993 (S.I. 1993/2619) West Cheshire National Health Service Trust (Establishment) Order 1993 (S.I. 1993/2620) South Kent Community Healthcare National Health Service Trust (Establishment) Order 1993 (S.I. 1993/2621) Stockport Acute Services National Health Service Trust (Establishment) Order 1993 (S.I. 1993/2622) Guild Community Healthcare National Health Service Trust (Establishment) Order 1993 (S.I. 1993/2623) North Tyneside Health Care National Health Service Trust (Establishment) Order 1993 (S.I. 1993/2624) Preston Acute Hospitals National Health Service Trust (Establishment) Order 1993 (S.I. 1993/2625) Tameside and Glossop Community and Priority Services National Health Service Trust (Establishment) Order 1993 (S.I. 1993/2626) Hartlepool and Peterlee Hospitals National Health Service Trust (Establishment) Order 1993 (S.I. 1993/2627) Stockport Healthcare National Health Service Trust (Establishment) Order 1993 (S.I. 1993/2628) New Possibilities National Health Service Trust (Establishment) Order 1993 (S.I.
Sources: en.wikipedia.org
尚未。它仍处于临床研究阶段，任何监管批准都取决于正在进行的试验结果和提交审评。可公开获取的信息以试验注册和会议摘要为主。
司美格鲁肽主要靶向GLP-1受体，而瑞他鲁肽同时作用于GLP-1、GIP和胰高血糖素受体。这种三重机制旨在产生不同的代谢效应，但临床差异仍需头对头研究确认。
长期心血管结局、停药后维持效果、罕见不良事件和不同人群中的获益风险比尚未完全确定。完整三期数据和监管审评将影响结论。
A responder analysis counts participants who cross a threshold, such as five or ten percent weight loss. It complements average percent change by showing how widely results are distributed. The two measures can diverge when a subset of participants loses a large amount.